Home Medicine Influence of storage conditions on the release of growth factors in platelet-rich blood derivatives
Article Open Access

Influence of storage conditions on the release of growth factors in platelet-rich blood derivatives

  • Katharina Düregger EMAIL logo , Anqi Peng and Markus Eblenkamp
Published/Copyright: September 30, 2016

Abstract

Thrombocytes can be concentrated in blood derivatives and used as autologous transplants e.g. for wound treatment due to the release of growth factors such as platelet derived growth factor (PDGF). Conditions for processing and storage of these platelet-rich blood derivatives influence the release of PDGF from the platelet-bound α-granules into the plasma. In this study Platelet rich plasma (PRP) and Platelet concentrate (PC) were produced with a fully automated centrifugation system. Storage of PRP and PC for 1 h up to 4 months at temperatures between −20°C and +37°C was applied with the aim of evaluating the influence on the amount of released PDGF. Storage at −20°C resulted in the highest release of PDGF in PRP and a time dependency was determined: prolonged storage up to 1 month in PRP and 10 days in PC increased the release of PDGF. Regardless of the storage conditions, the release of PDGF per platelet was higher in PC than in PRP.

1 Introduction

Platelet-rich blood derivatives are used as autologous transplants in the field of wound care, general surgery and sports medicine [1]. The main factor for the promotion of healing by applying autologous blood products are growth factors (GF) released by thrombocytes, like platelet derived growth factor (PDGF) [2].

Physiologically growth factors are released after thrombocyte activation due to contact with collagen and other thrombocytes [3]. The initial release of GF due to activation is followed by degradation of the platelets. In vitro contact with foreign surfaces and physical influences such as mechanical (e.g. centrifugation) or thermal (e.g. freezing) stresses additionally activate or disintegrate platelets [4].

A frequently pursued approach in the generation of platelet-rich blood derivatives is preserving the integrity of the platelets to allow a physiological thrombocyte activation after transplantation to the injured area. A contrasting approach is applying blood derivatives rich in released GF to the area in need of a promoted healing effect. It is still unclear which approach results in an optimal global effect [2], [4].

In this context the aim of the present study was to evaluate the influence of storage conditions (temperature and time) on the release of growth factors in autologous platelet-rich blood derivatives.

2 Methods

2.1 Processing of PRP and PC

Venous blood was drawn from healthy donors with 12 ml syringes prefilled with 1 ml of citrate (4% sodium citrate, Duomedica GmbH). The filled syringes (11 ml blood, 1 ml citrate) were connected to empty syringes of equal size with a hose. The connected syringe pair was inserted into a standard laboratory centrifuge (Rotanta 460, Hettich) equipped with a rotor developed for fully automated preparation of blood derivatives. The motorized and sensor controlled system separates the blood fractions within the centrifugation process (see Figure 1).

Figure 1 Generation of PRP and PC: Separation of the blood fractions in syringe A after the first centrifugation step (1) followed by a sensor controlled transfer process resulting in PRP in syringe B (2). PC was obtained in syringe B by a second centrifugation step (3) and transfer process (4).
Figure 1

Generation of PRP and PC: Separation of the blood fractions in syringe A after the first centrifugation step (1) followed by a sensor controlled transfer process resulting in PRP in syringe B (2). PC was obtained in syringe B by a second centrifugation step (3) and transfer process (4).

After the first centrifugation step at 930 g for 5 min plasma and buffy coat are transferred into the connected syringe B until the sensor detects the red blood cells and stops the transfer process. This leads to a donor dependant volume of 5–6 ml of PRP in syringe B.

A second centrifugation step at 475 g for 27 min results in the separation of platelet poor plasma (PPP) and PC within syringe B. The PPP fraction of syringe B is transferred back into syringe A, leaving 1 ml of PC in syringe B. During all transfer processes a centrifugation force of 20 g is maintained.

The platelet yield was determined by comparing the number of platelets in the freshly drawn whole blood before preparation and in the blood derivatives after processing. A haematology analyser (KX 21N, Sysmex Europe GmbH) was used.

2.2 Experimental setup

Storage times and temperatures were chosen based on the recommendations stated by the German Medical Association [5]. PRP samples were stored between 1 h and 4 months and PC samples between 1 h and 10 days. The examined storage temperatures were +4°C, +22°C and +37°C for PC and additionally −20°C for PRP.

After storage all samples were brought to room temperature and the amount of released PDGF was determined by ELISA (Human PDGF Duoset ELISA Kit – R&D Systems, Minneapolis, USA).

3 Results

The results were determined as the absolute amount of released PDGF and the amount released per 106 platelets by considering the platelet count.

3.1 Platelet rich plasma

The average yield of platelets in PRP gained from freshly drawn venous blood samples was 97.2 ± 7.8% with a platelet concentration of 402 ± 24 × 103 plt/μl (1.75 ± 0.13 fold compared to the unprocessed whole blood sample: n = 15).

The content of PDGF in PRP was measured and averaged over 3 donors (see Figure 2). PDGF content increased with storage times within the 1st month and subsequently slightly decreased within the following 3 months, regardless of the storage temperature. For all storage times the highest values were reached at −20°C storage temperature.

Figure 2 PDGF release in PRP averaged over 3 donors after storage between 1 h and 4 months at −20°C, +4°C, +22°C, and +37°C. PDGF increases with storage time for all temperatures and the highest value is reached at −20°C for all storage times.
Figure 2

PDGF release in PRP averaged over 3 donors after storage between 1 h and 4 months at −20°C, +4°C, +22°C, and +37°C. PDGF increases with storage time for all temperatures and the highest value is reached at −20°C for all storage times.

In addition the PDGF release per 106 platelets was calculated based on the number of platelets measured in the samples before storage (see Table 1). An increase of PDGF release within the 1st month of storage and decrease within the following 3 months, regardless of the storage temperature was also evident here. The highest overall rate was reached after storage of PRP for 1 month at −20°C with 33 pg per 106 platelets.

Table 1

Amount of PDGF released per 106 platelets [pg/106] in PRP after storage between 1 h and 4 months at −20°C, +4°C, +22°C, and +37°C averaged over 3 donors.

n =3−20°C+4°C+22°C+37°C
1 h6.7 ± 6.32.6 ± 1.01.9 ± 0.91.5 ± 0.6
24 h16.6 ± 2.37.1 ± 0.73.2 ± 1.04.7 ± 1.7
48 h16.3 ± 1.67.4 ± 1.05.5 ± 1.15.9 ± 1.4
1 month30.6 ± 2.025.2 ± 3.925.3 ± 4.026.9 ± 1.1
4 months22.0 ± 0.521.7 ± 0.620.3 ± 0.6

3.2 Platelet concentrate

The average yield of platelets in PC gained from freshly drawn whole blood samples was 69.4 ± 21.3% with a platelet concentration of 1528 ± 477 × 103 plt/μl (6.64 ± 2.13 fold compared to the whole blood sample: n = 18).

The content of PDGF in PC was measured and averaged over 3 donors (see Figure 3). PDGF content increased with storage time within 10 days of storage, regardless of the storage temperature. PDGF release within the first 72 h was comparable for all storage. Chilled storage at +4°C resulted in the highest PDGF content within the following 7 days.

Figure 3 PDGF release in PC averaged over 3 donors after storage between 1 h and 10 days at +4°C, +22°C, and +37°C. PDGF increases with storage time for all temperatures and the highest value is reached at +4°C after 10 days.
Figure 3

PDGF release in PC averaged over 3 donors after storage between 1 h and 10 days at +4°C, +22°C, and +37°C. PDGF increases with storage time for all temperatures and the highest value is reached at +4°C after 10 days.

The PDGF release per 106 platelets was calculated based on the number of platelets measured before storage (see Table 2). The highest amount of PDGF per 106 platelets was reached at +22°C for all storage times within the first 72 h and at +4°C in the following 7 days. The release increased with prolonged storage time for each temperature. The highest overall rate was reached in a PC sample from donor 1 stored for 10 days at 4°C with a calculated value of 67.0 pg per 106 platelets.

Table 2

Amount of PDGF released per 106 platelets [pg/106] in PC after storage between 1 h and 10 days at +4°C, +22°C, and +37°C averaged over 3 donors.

n =3+4°C+22°C+37°C
1 h4.3 ± 3.25.3 ± 3.65.1 ± 1.9
24 h6.3 ± 1.89.0 ± 3.17.6 ± 2.9
48 h13.5 ± 10.023.4 ± 11.212.4 ± 4.8
72 h19.2 ± 7.922.0 ± 4.420.8 ± 6.7
10 day43.4 ± 20.232.9 ± 17.328.5 ± 9.7

4 Discussion

Platelet-rich blood derivatives contain multiple growth factors with positive effects on the treatment of injured areas [2]. As PDGF is one of the most important and well-characterized growth factors it was chosen as a representative and marker in this study. Our aim was to evaluate the release of PDGF from the platelet-bound α-granules into the plasma induced by storage conditions, regardless of the intended therapeutic approach. Nevertheless the findings provide information for the objective of low platelet activation as well as maximised release of growth factors in the blood derivatives.

The first influence on PDGF release in blood derivatives is the production process. We used a fully automated system to generate PRP and PC leading to a highly reproducible process compared to standard preparation processes comprising manual steps. Thus reasons for variations of the platelet yield can be reduced to donor dependent differences.

In both PRP and PC the increased release of PDGF with storage time can be explained by activation induced by mechanical and thermal stress [4] followed by degranulation and disintegration of thrombocytes. Disintegration of blood cells leads to false platelet measurements in haematology analysers [6]. Thus, variations of the platelet number after storage might be considered as an indicator for degradation and disintegration of the thrombocytes. This results in loss of physiological activity and integrity of the platelets as desired in some therapeutic approaches. In PRP only small changes were detected in the number of platelets measured within the first 48 h of storage above +4°C indicating that mainly platelet activation and not disintegration caused the PDGF release. For prolonged and frozen storage high fluctuations of the platelet count were determined in PRP and disintegration of the platelets is assumed. In PC this was already observed in the first 72 h of storage.

4.1 Platelet rich plasma

In PRP nearly no difference was noticed in the PDGF content between the tested storage temperatures after 1 month of storage. Storage of the platelets above +4°C lead to a continuous release of PDGF almost levelling with the amount released at −20°C after 1 month. The following decrease of the PDGF content at all temperatures might be due to denaturation of the released growth factors. The theoretically possible maximum level of 60 pg per 106 platelets bound in the α-granules [7] was not reached in the blood derivatives.

A further observation in the frozen samples of PRP which might explain the higher values of PDGF was a very homogenous composition with no apparent phase separation. Due to the static storage without agitation the blood derivatives stored at +4°C, +22°C, and +37°C had visible phase separation. This could result in variations of the pH value and thus in denaturation of proteins explaining the lower PDGF content. By quickly freezing the blood derivatives stored at −20°C no phase separation was possible despite the equally static storage conditions.

4.2 Platelet concentrate

In PC the thrombocytes are more densely packed than in PRP due to the higher concentration. Contact activation of the densely packed platelets needs to be taken into account. Also the greater physical influence of the two step centrifugation process has an effect on the release of growth factors.

The PDGF concentration in all PC samples was higher than in PRP, which could be explained by the higher platelet content. However higher values were also detected when comparing the PDGF amounts standardized to the platelet count. Within the first 10 days of storage the amount of PDGF released per 106 platelets in PC was higher than the overall maximum in PRP, regardless of the storage conditions. Furthermore the release within 72 h in PC already equalled the amount released in PRP within 1 month of storage.

This indicates that PDGF release in PC is distinctly accelerated compared to PRP and might be due to the stronger activation during production and contact activation. The values of PDGF per 106 platelets are also closer to the maximum possible physiological level of 60 pg per 106 platelets. In addition storage at −20°C could be a promising condition for an even higher yield and complete release of growth factors in PC.

5 Conclusion

Storage of platelet-rich blood derivatives resulted in an increased release of PDGF from the platelet-bound α-granules into the plasma with storage time up to 1 month in PRP and 10 days in PC, regardless of the storage temperature. PDGF release per platelet in PC was distinctly accelerated compared with PRP and almost reached the physiologically possible level of 60 pg per 106 platelets. Highest PDGF levels were reached in chilled or frozen storage with accelerated PDGF release in PRP at −20°C. The findings provide information for the objective of low platelet activation as well as maximised release of growth factors in blood derivatives due to storage conditions.

Acknowledgement

The authors are grateful to Andreas Hettich GmbH & Co.KG for the project support.

Author’s Statement

Research funding: The author state no funding involved. Conflict of interest: Authors state no conflict of interest. Material and methods: Informed consent: Informed consent has been obtained from all individuals included in this study. Ethical approval: The research related to human use complies with all the relevant national regulations, institutional policies and was performed in accordance with the tenets of the Helsinki Declaration, and has been approved by the authors’ institutional review board or equivalent committee.

References

[1] Amable PR, Carias RB, Teixeira MV, da Cruz Pacheco Í, Corrêa do Amaral RJ, Granjeiro J, et al. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther. 2013;4:67.10.1186/scrt218Search in Google Scholar PubMed PubMed Central

[2] De Pascale MR, Sommese L, Casamassimi A, Napoli C. Platelet derivatives in regenerative medicine: an update. Transfus Med Rev. 2015;29:52–61.10.1016/j.tmrv.2014.11.001Search in Google Scholar PubMed

[3] Meinrad G. Das Blutplättchen. Thieme-Verlag 1999.Search in Google Scholar

[4] Perrotta PL. Snyder EL. CHAPTER 69 - Platelet Storage and Transfusion A2 - Michelson, Alan D. In: Platelets (Second Edition), (Hrsg.), Academic Press, Burlington 2007;1265–95.10.1016/B978-012369367-9/50831-4Search in Google Scholar

[5] Bundesärztekammer WB. Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie), Dt. Ärzte-Verlag 2002.Search in Google Scholar

[6] Briggs C, Harrison P, Machin SJ. CHAPTER 24 - Platelet Counting A2 - Michelson, Alan D. In: Platelets (Second Edition), (Hrsg.), Academic Press, Burlington 2007;475–83.10.1016/B978-012369367-9/50786-2Search in Google Scholar

[7] Kudlow JE. Biology of growth factors: molecular biology, oncogenes, signal transduction, and clinical implications. Springer Science & Business Media 2013;234.Search in Google Scholar

Published Online: 2016-9-30
Published in Print: 2016-9-1

©2016 Katharina Düregger et al., licensee De Gruyter.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Articles in the same Issue

  1. Synthesis and characterization of PIL/pNIPAAm hybrid hydrogels
  2. Novel blood protein based scaffolds for cardiovascular tissue engineering
  3. Cell adhesion and viability of human endothelial cells on electrospun polymer scaffolds
  4. Effects of heat treatment and welding process on superelastic behaviour and microstructure of micro electron beam welded NiTi
  5. Long-term stable modifications of silicone elastomer for improved hemocompatibility
  6. The effect of thermal treatment on the mechanical properties of PLLA tubular specimens
  7. Biocompatible wear-resistant thick ceramic coating
  8. Protection of active implant electronics with organosilicon open air plasma coating for plastic overmolding
  9. Examination of dielectric strength of thin Parylene C films under various conditions
  10. Open air plasma deposited antimicrobial SiOx/TiOx composite films for biomedical applications
  11. Systemic analysis about residual chloroform in PLLA films
  12. A macrophage model of osseointegration
  13. Towards in silico prognosis using big data
  14. Technical concept and evaluation of a novel shoulder simulator with adaptive muscle force generation and free motion
  15. Usability evaluation of a locomotor therapy device considering different strategies
  16. Hypoxia-on-a-chip
  17. Integration of a semi-automatic in-vitro RFA procedure into an experimental setup
  18. Fabrication of MEMS-based 3D-μECoG-MEAs
  19. High speed digital interfacing for a neural data acquisition system
  20. Bionic forceps for the handling of sensitive tissue
  21. Experimental studies on 3D printing of barium titanate ceramics for medical applications
  22. Patient specific root-analogue dental implants – additive manufacturing and finite element analysis
  23. 3D printing – a key technology for tailored biomedical cell culture lab ware
  24. 3D printing of hydrogels in a temperature controlled environment with high spatial resolution
  25. Biocompatibility of photopolymers for additive manufacturing
  26. Biochemical piezoresistive sensors based on pH- and glucose-sensitive hydrogels for medical applications
  27. Novel wireless measurement system of pressure dedicated to in vivo studies
  28. Portable auricular device for real-time swallow and chew detection
  29. Detection of miRNA using a surface plasmon resonance biosensor and antibody amplification
  30. Simulation and evaluation of stimulation scenarios for targeted vestibular nerve excitation
  31. Deep brain stimulation: increasing efficiency by alternative waveforms
  32. Prediction of immediately occurring microsleep events from brain electric signals
  33. Determining cardiac vagal threshold from short term heart rate complexity
  34. Classification of cardiac excitation patterns during atrial fibrillation
  35. An algorithm to automatically determine the cycle length coverage to identify rotational activity during atrial fibrillation – a simulation study
  36. Deriving respiration from high resolution 12-channel-ECG during cycling exercise
  37. Reducing of gradient induced artifacts on the ECG signal during MRI examinations using Wilcoxon filter
  38. Automatic detection and mapping of double potentials in intracardiac electrograms
  39. Modeling the pelvic region for non-invasive pelvic intraoperative neuromonitoring
  40. Postprocessing algorithm for automated analysis of pelvic intraoperative neuromonitoring signals
  41. Best practice: surgeon driven application in pelvic operations
  42. Vasomotor assessment by camera-based photoplethysmography
  43. Classification of morphologic changes in photoplethysmographic waveforms
  44. Novel computation of pulse transit time from multi-channel PPG signals by wavelet transform
  45. Efficient design of FIR filter based low-pass differentiators for biomedical signal processing
  46. Nonlinear causal influences assessed by mutual compression entropy
  47. Comparative study of methods for solving the correspondence problem in EMD applications
  48. fNIRS for future use in auditory diagnostics
  49. Semi-automated detection of fractional shortening in zebrafish embryo heart videos
  50. Blood pressure measurement on the cheek
  51. Derivation of the respiratory rate from directly and indirectly measured respiratory signals using autocorrelation
  52. Left cardiac atrioventricular delay and inter-ventricular delay in cardiac resynchronization therapy responder and non-responder
  53. An automatic systolic peak detector of blood pressure waveforms using 4th order cumulants
  54. Real-time QRS detection using integrated variance for ECG gated cardiac MRI
  55. Preprocessing of unipolar signals acquired by a novel intracardiac mapping system
  56. In-vitro experiments to characterize ventricular electromechanics
  57. Continuous non-invasive monitoring of blood pressure in the operating room: a cuffless optical technology at the fingertip
  58. Application of microwave sensor technology in cardiovascular disease for plaque detection
  59. Artificial blood circulatory and special Ultrasound Doppler probes for detecting and sizing gaseous embolism
  60. Detection of microsleep events in a car driving simulation study using electrocardiographic features
  61. A method to determine the kink resistance of stents and stent delivery systems according to international standards
  62. Comparison of stented bifurcation and straight vessel 3D-simulation with a prior simulated velocity profile inlet
  63. Transient Euler-Lagrange/DEM simulation of stent thrombosis
  64. Automated control of the laser welding process of heart valve scaffolds
  65. Automation of a test bench for accessing the bendability of electrospun vascular grafts
  66. Influence of storage conditions on the release of growth factors in platelet-rich blood derivatives
  67. Cryopreservation of cells using defined serum-free cryoprotective agents
  68. New bioreactor vessel for tissue engineering of human nasal septal chondrocytes
  69. Determination of the membrane hydraulic permeability of MSCs
  70. Climate retainment in carbon dioxide incubators
  71. Multiple factors influencing OR ventilation system effectiveness
  72. Evaluation of an app-based stress protocol
  73. Medication process in Styrian hospitals
  74. Control tower to surgical theater
  75. Development of a skull phantom for the assessment of implant X-ray visibility
  76. Surgical navigation with QR codes
  77. Investigation of the pressure gradient of embolic protection devices
  78. Computer assistance in femoral derotation osteotomy: a bottom-up approach
  79. Automatic depth scanning system for 3D infrared thermography
  80. A service for monitoring the quality of intraoperative cone beam CT images
  81. Resectoscope with an easy to use twist mechanism for improved handling
  82. In vitro simulation of distribution processes following intramuscular injection
  83. Adjusting inkjet printhead parameters to deposit drugs into micro-sized reservoirs
  84. A flexible standalone system with integrated sensor feedback for multi-pad electrode FES of the hand
  85. Smart control for functional electrical stimulation with optimal pulse intensity
  86. Tactile display on the remaining hand for unilateral hand amputees
  87. Effects of sustained electrical stimulation on spasticity assessed by the pendulum test
  88. An improved tracking framework for ultrasound probe localization in image-guided radiosurgery
  89. Improvement of a subviral particle tracker by the use of a LAP-Kalman-algorithm
  90. Learning discriminative classification models for grading anal intraepithelial neoplasia
  91. Regularization of EIT reconstruction based on multi-scales wavelet transforms
  92. Assessing MRI susceptibility artefact through an indicator of image distortion
  93. EyeGuidance – a computer controlled system to guide eye movements
  94. A framework for feedback-based segmentation of 3D image stacks
  95. Doppler optical coherence tomography as a promising tool for detecting fluid in the human middle ear
  96. 3D Local in vivo Environment (LivE) imaging for single cell protein analysis of bone tissue
  97. Inside-Out access strategy using new trans-vascular catheter approach
  98. US/MRI fusion with new optical tracking and marker approach for interventional procedures inside the MRI suite
  99. Impact of different registration methods in MEG source analysis
  100. 3D segmentation of thyroid ultrasound images using active contours
  101. Designing a compact MRI motion phantom
  102. Cerebral cortex classification by conditional random fields applied to intraoperative thermal imaging
  103. Classification of indirect immunofluorescence images using thresholded local binary count features
  104. Analysis of muscle fatigue conditions using time-frequency images and GLCM features
  105. Numerical evaluation of image parameters of ETR-1
  106. Fabrication of a compliant phantom of the human aortic arch for use in Particle Image Velocimetry (PIV) experimentation
  107. Effect of the number of electrodes on the reconstructed lung shape in electrical impedance tomography
  108. Hardware dependencies of GPU-accelerated beamformer performances for microwave breast cancer detection
  109. Computer assisted assessment of progressing osteoradionecrosis of the jaw for clinical diagnosis and treatment
  110. Evaluation of reconstruction parameters of electrical impedance tomography on aorta detection during saline bolus injection
  111. Evaluation of open-source software for the lung segmentation
  112. Automatic determination of lung features of CF patients in CT scans
  113. Image analysis of self-organized multicellular patterns
  114. Effect of key parameters on synthesis of superparamagnetic nanoparticles (SPIONs)
  115. Radiopacity assessment of neurovascular implants
  116. Development of a desiccant based dielectric for monitoring humidity conditions in miniaturized hermetic implantable packages
  117. Development of an artifact-free aneurysm clip
  118. Enhancing the regeneration of bone defects by alkalizing the peri-implant zone – an in vitro approach
  119. Rapid prototyping of replica knee implants for in vitro testing
  120. Protecting ultra- and hyperhydrophilic implant surfaces in dry state from loss of wettability
  121. Advanced wettability analysis of implant surfaces
  122. Patient-specific hip prostheses designed by surgeons
  123. Plasma treatment on novel carbon fiber reinforced PEEK cages to enhance bioactivity
  124. Wear of a total intervertebral disc prosthesis
  125. Digital health and digital biomarkers – enabling value chains on health data
  126. Usability in the lifecycle of medical software development
  127. Influence of different test gases in a non-destructive 100% quality control system for medical devices
  128. Device development guided by user satisfaction survey on auricular vagus nerve stimulation
  129. Empirical assessment of the time course of innovation in biomedical engineering: first results of a comparative approach
  130. Effect of left atrial hypertrophy on P-wave morphology in a computational model
  131. Simulation of intracardiac electrograms around acute ablation lesions
  132. Parametrization of activation based cardiac electrophysiology models using bidomain model simulations
  133. Assessment of nasal resistance using computational fluid dynamics
  134. Resistance in a non-linear autoregressive model of pulmonary mechanics
  135. Inspiratory and expiratory elastance in a non-linear autoregressive model of pulmonary mechanics
  136. Determination of regional lung function in cystic fibrosis using electrical impedance tomography
  137. Development of parietal bone surrogates for parietal graft lift training
  138. Numerical simulation of mechanically stimulated bone remodelling
  139. Conversion of engineering stresses to Cauchy stresses in tensile and compression tests of thermoplastic polymers
  140. Numerical examinations of simplified spondylodesis models concerning energy absorption in magnetic resonance imaging
  141. Principle study on the signal connection at transabdominal fetal pulse oximetry
  142. Influence of Siluron® insertion on model drug distribution in the simulated vitreous body
  143. Evaluating different approaches to identify a three parameter gas exchange model
  144. Effects of fibrosis on the extracellular potential based on 3D reconstructions from histological sections of heart tissue
  145. From imaging to hemodynamics – how reconstruction kernels influence the blood flow predictions in intracranial aneurysms
  146. Flow optimised design of a novel point-of-care diagnostic device for the detection of disease specific biomarkers
  147. Improved FPGA controlled artificial vascular system for plethysmographic measurements
  148. Minimally spaced electrode positions for multi-functional chest sensors: ECG and respiratory signal estimation
  149. Automated detection of alveolar arches for nasoalveolar molding in cleft lip and palate treatment
  150. Control scheme selection in human-machine- interfaces by analysis of activity signals
  151. Event-based sampling for reducing communication load in realtime human motion analysis by wireless inertial sensor networks
  152. Automatic pairing of inertial sensors to lower limb segments – a plug-and-play approach
  153. Contactless respiratory monitoring system for magnetic resonance imaging applications using a laser range sensor
  154. Interactive monitoring system for visual respiratory biofeedback
  155. Development of a low-cost senor based aid for visually impaired people
  156. Patient assistive system for the shoulder joint
  157. A passive beating heart setup for interventional cardiology training
Downloaded on 27.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/cdbme-2016-0069/html
Scroll to top button